Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
Antoni, C, Krueger, G G, de Vlam, K, Birbara, C, Beutler, A, Guzzo, C, Zhou, B, Dooley, L T, Kavanaugh, A
Published in Annals of the rheumatic diseases (01.08.2005)
Published in Annals of the rheumatic diseases (01.08.2005)
Get full text
Journal Article
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U, Romano, P, Mulcahy, LD, Dooley, LT, Baker, DG, Gottlieb, AB
Published in The Lancet (British edition) (09.06.2001)
Published in The Lancet (British edition) (09.06.2001)
Get full text
Journal Article
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial
Kavanaugh, A, Krueger, G G, Beutler, A, Guzzo, C, Zhou, B, Dooley, L T, Mease, P J, Gladman, D D, de Vlam, K, Geusens, P P, Birbara, C, Halter, D G, Antoni, C
Published in Annals of the rheumatic diseases (01.04.2007)
Published in Annals of the rheumatic diseases (01.04.2007)
Get full text
Journal Article
Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial
Feldman, S.R., Gordon, K.B., Bala, M., Evans, R., Li, S., Dooley, L.T., Guzzo, C., Patel, K., Menter, A., Gottlieb, A.B.
Published in British journal of dermatology (1951) (01.05.2005)
Published in British journal of dermatology (1951) (01.05.2005)
Get full text
Journal Article
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis
Kavanaugh, A, Antoni, C, Krueger, G G, Yan, S, Bala, M, Dooley, L T, Beutler, A, Guzzo, C, Gladman, D
Published in Annals of the rheumatic diseases (01.04.2006)
Published in Annals of the rheumatic diseases (01.04.2006)
Get full text
Journal Article
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis
Feldman, S.R., Gottlieb, A.B., Bala, M., Wu, Y., Eisenberg, D., Guzzo, C., Li, S., Dooley, L.T., Menter, A.
Published in British journal of dermatology (1951) (01.09.2008)
Published in British journal of dermatology (1951) (01.09.2008)
Get full text
Journal Article
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial
Reich, K., Nestle, F.O., Papp, K., Ortonne, J.-P., Wu, Y., Bala, M., Evans, R., Guzzo, C., Li, S., Dooley, L.T., Griffiths, C.E.M.
Published in British journal of dermatology (1951) (01.06.2006)
Published in British journal of dermatology (1951) (01.06.2006)
Get full text
Journal Article
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2
van der Heijde, D., Kavanaugh, A., Gladman, D. D., Antoni, C., Krueger, G. G., Guzzo, C., Zhou, B., Dooley, L. T., de Vlam, K., Geusens, P., Birbara, C., Halter, D., Beutler, A.
Published in Arthritis and rheumatism (01.08.2007)
Published in Arthritis and rheumatism (01.08.2007)
Get full text
Journal Article
A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis
Krueger, Gerald G, Langley, Richard G, Leonardi, Craig, Yeilding, Newman, Guzzo, Cynthia, Wang, Yuhua, Dooley, Lisa T, Lebwohl, Mark
Published in The New England journal of medicine (08.02.2007)
Published in The New England journal of medicine (08.02.2007)
Get full text
Journal Article
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
Reich, Kristian, Nestle, Frank O, Papp, Kim, Ortonne, Jean-Paul, Evans, Robert, Guzzo, Cynthia, Li, Shu, Dooley, Lisa T, Griffiths, Christopher EM
Published in The Lancet (British edition) (15.10.2005)
Published in The Lancet (British edition) (15.10.2005)
Get full text
Journal Article
Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial
Gottlieb, Alice B., Evans, Robert, Li, Shu, Dooley, Lisa T., Guzzo, Cynthia A., Baker, Daniel, Bala, Mohan, Marano, Colleen W., Menter, Alan
Published in Journal of the American Academy of Dermatology (01.10.2004)
Published in Journal of the American Academy of Dermatology (01.10.2004)
Get full text
Journal Article
THERAPEUTICS: Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial
Reich, K, Nestle, F O, Papp, K, Ortonne, J-P, Wu, Y, Bala, M, Evans, R, Guzzo, C, Li, S, Dooley, L T, Griffiths, CEM
Published in British journal of dermatology (1951) (01.06.2006)
Published in British journal of dermatology (1951) (01.06.2006)
Get full text
Journal Article
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
Gottlieb, Alice B., Masuda, Salman, Ramamurthi, Rallapalli, Abdulghani, Ahsan, Romano, Pat, Chaudhari, Umesh, Dooley, Lisa T., Fasanmade, Adedigbo A., Wagner, Carrie L.
Published in Journal of the American Academy of Dermatology (01.01.2003)
Published in Journal of the American Academy of Dermatology (01.01.2003)
Get full text
Journal Article
ORIGINAL ARTICLE: Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial
Feldman, SR, Gordon, K B, Bala, M, Evans, R, Li, S, Dooley, L T, Guzzo, C, Patel, K, Menter, A, Gottlieb, AB
Published in British journal of dermatology (1951) (01.05.2005)
Published in British journal of dermatology (1951) (01.05.2005)
Get full text
Journal Article
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Leonardi, CL, Kimball, AB, Papp, KA, Yeilding, N, Guzzo, C, Wang, Y, Li, S, Dooley, L T, Gordon, K B
Published in The Lancet (North American edition) (23.05.2008)
Get full text
Published in The Lancet (North American edition) (23.05.2008)
Journal Article
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Papp, KA, Langley, R G, Lebwohl, M, Krueger, G G, Szapary, P, Yeilding, N, Guzzo, C, Hsu, M-C, Wang, Y, Li, S, Dooley, L T, Reich, K
Published in The Lancet (North American edition) (23.05.2008)
Get full text
Published in The Lancet (North American edition) (23.05.2008)
Journal Article